These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1387 related items for PubMed ID: 31806131

  • 1. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR, Reddy VY, Gordon NT, Delurgio D, Doshi SK, Desai AJ, Stone JE, Kar S.
    J Am Coll Cardiol; 2019 Dec 10; 74(23):2878-2889. PubMed ID: 31806131
    [Abstract] [Full Text] [Related]

  • 2. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, Horton RP, Buchbinder M, Neuzil P, Gordon NT, Holmes DR, PREVAIL and PROTECT AF Investigators.
    J Am Coll Cardiol; 2017 Dec 19; 70(24):2964-2975. PubMed ID: 29103847
    [Abstract] [Full Text] [Related]

  • 3. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR, Kar S, Holmes DR, Doshi SK, Swarup V, Gibson DN, Maini B, Gordon NT, Main ML, Reddy VY.
    Circulation; 2018 Aug 28; 138(9):874-885. PubMed ID: 29752398
    [Abstract] [Full Text] [Related]

  • 4. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L, Wong YH, Reddy VY, Boersma LVA, Bergmann MW, Doshi S, Kar S, Sievert H, Wehrenberg S, Stein K, Holmes DR.
    JACC Cardiovasc Interv; 2019 Jun 10; 12(11):1055-1063. PubMed ID: 31171282
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years.
    Yu J, Chen H, Post F, Muenzel M, Keil T, Hou CR, Zhao M, Meng Z, Jiang L.
    Heart Vessels; 2019 Nov 10; 34(11):1858-1865. PubMed ID: 31144099
    [Abstract] [Full Text] [Related]

  • 6. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY.
    J Am Coll Cardiol; 2014 Jul 08; 64(1):1-12. PubMed ID: 24998121
    [Abstract] [Full Text] [Related]

  • 7. Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
    Dukkipati SR, Holmes DR, Doshi SK, Kar S, Singh SM, Gibson D, Price MJ, Natale A, Mansour M, Sievert H, Houle VM, Allocco DJ, Reddy VY.
    J Am Coll Cardiol; 2022 Aug 02; 80(5):469-483. PubMed ID: 35902169
    [Abstract] [Full Text] [Related]

  • 8. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
    Holmes DR, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H, Valderrabano M, Reddy VY.
    J Am Coll Cardiol; 2015 Jun 23; 65(24):2614-2623. PubMed ID: 26088300
    [Abstract] [Full Text] [Related]

  • 9. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF, Kar S, Douglas P, Dukkipati S, Feldman T, Horton R, Holmes D, Reddy VY.
    J Am Coll Cardiol; 2012 Mar 06; 59(10):923-9. PubMed ID: 22381428
    [Abstract] [Full Text] [Related]

  • 10. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
    López-Mínguez JR, Nogales-Asensio JM, Infante De Oliveira E, De Gama Ribeiro V, Ruiz-Salmerón R, Arzamendi-Aizpurua D, Costa M, Gutiérrez-García H, Fernández-Díaz JA, Martín-Yuste V, Rama-Merchán JC, Moreno-Gómez R, Benedicto-Buendía A, Íñiguez-Romo A.
    Rev Esp Cardiol (Engl Ed); 2019 Jun 06; 72(6):449-455. PubMed ID: 29754808
    [Abstract] [Full Text] [Related]

  • 11. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
    Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H.
    J Am Coll Cardiol; 2013 Jun 25; 61(25):2551-6. PubMed ID: 23583249
    [Abstract] [Full Text] [Related]

  • 12. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR, Metawee M, Piana RN, Bennett JM, Pretorius M, Deegan RJ.
    Heart Rhythm; 2019 Jan 25; 16(1):12-17. PubMed ID: 30012348
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study.
    Huang WP, Zhang YH, He L, Su X, Yang XW, Guo ZX.
    Chin Med J (Engl); 2017 Feb 20; 130(4):434-438. PubMed ID: 28218217
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　- First Results From the SALUTE Trial.
    Aonuma K, Yamasaki H, Nakamura M, Ootomo T, Takayama M, Ando K, Hirao K, Morino Y, Hayashida K, Kusano K, Main ML, Saito S.
    Circ J; 2018 Nov 24; 82(12):2946-2953. PubMed ID: 30305484
    [Abstract] [Full Text] [Related]

  • 15. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X, Jiang L, Duenninger E, Muenzel M, Guan S, Fazakas A, Cheng F, Illnitzky J, Keil T, Yu J.
    Heart Vessels; 2018 Sep 24; 33(9):1068-1075. PubMed ID: 29564543
    [Abstract] [Full Text] [Related]

  • 16. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
    Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S.
    Circulation; 2011 Feb 01; 123(4):417-24. PubMed ID: 21242484
    [Abstract] [Full Text] [Related]

  • 17. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
    Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D, PROTECT AF Investigators.
    Circulation; 2013 Feb 12; 127(6):720-9. PubMed ID: 23325525
    [Abstract] [Full Text] [Related]

  • 18. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry.
    Kefer J, Vermeersch P, Budts W, Depotter T, Aminian A, Benit E, Stammen F.
    Acta Cardiol; 2013 Dec 12; 68(6):551-8. PubMed ID: 24579432
    [Abstract] [Full Text] [Related]

  • 19. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY, Akehurst RL, Gavaghan MB, Amorosi SL, Holmes DR.
    J Am Heart Assoc; 2019 Jul 02; 8(13):e011577. PubMed ID: 31230500
    [Abstract] [Full Text] [Related]

  • 20. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
    Raghuram P, Pavithran S, Sivakumar K.
    Indian Heart J; 2020 Jul 02; 72(5):369-375. PubMed ID: 33189196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.